A. Ripamonti
Azienda Ospedaliera San Gerardo(IT)Istituti di Ricovero e Cura a Carattere Scientifico(IT)University of Milano-Bicocca(IT)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Pharmacogenetics and Drug Metabolism, Acute Myeloid Leukemia Research, Hemoglobinopathies and Related Disorders, Metabolomics and Mass Spectrometry Studies
Most-Cited Works
- → Metabolism of deflazacort in the rat, dog and man.(1979)22 cited
- → Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study(2023)12 cited
- → Disposition and metabolism of a new steroidal anti-inflammatory agent, deflazacort, in cynomolgus monkeys(1983)8 cited
- → Neutrophil‐to‐lymphocyte ratio (NLR) at diagnosis in essential thrombocythemia: A new promising predictor of thrombotic events(2024)6 cited
- → Metabolic pathways of the anti-hypertensive agent, N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride. I. Studies in the rat(1985)5 cited
- → Metabolic fate of premazepam, a new anti-anxiety drug, in the rat and the dog.(1984)5 cited